Athira Pharma Inc. (ATHA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Athira Pharma Inc.

    NASDAQ: ATHA · Real-Time Price · USD
    3.84
    0.03 (0.79%)
    At close: Sep 26, 2025, 3:59 PM
    3.90
    1.56%
    After-hours: Sep 26, 2025, 07:31 PM EDT

    Athira Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 970K 969K 1.05M 479K
    Gross Profit
    		 -970K -969K -1.05M -479K
    Operating Income
    		 -100.9M -127.09M -104.02M -64.02M
    Interest Income
    		 3.96M 7.64M 3.22M 337K
    Pretax Income
    		 -96.94M -117.67M -95.64M -54.85M
    Net Income
    		 -96.94M -117.67M -95.64M -54.85M
    Selling & General & Admin
    		 26.09M 33.3M 32.55M 21.23M
    Research & Development
    		 69.71M 92.82M 61.46M 42.79M
    Other Expenses
    		 n/a n/a -1.05M -479K
    Operating Expenses
    		 95.81M 126.13M 92.97M 63.54M
    Interest Expense
    		 n/a n/a 24.32M 3K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 96.78M 127.09M 94.02M 64.02M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 3.85M 3.8M 3.77M 3.69M
    Shares Outstanding (Diluted)
    		 3.85M 3.8M 3.77M 3.69M
    EPS (Basic)
    		 -25.2 -30.9 -25.3 -14.9
    EPS (Diluted)
    		 -25.2 -30.9 -25.3 -14.9
    EBITDA
    		 -95.97M -116.7M -94.59M -54.37M
    EBIT
    		 -96.94M -117.67M -95.64M -54.85M
    Depreciation & Amortization
    		 970K 969K 1.05M 479K

    Add to Watchlist